0000784199-20-000143.txt : 20200522 0000784199-20-000143.hdr.sgml : 20200522 20200522154121 ACCESSION NUMBER: 0000784199-20-000143 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200520 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CRYOLIFE INC CENTRAL INDEX KEY: 0000784199 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 592417093 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13165 FILM NUMBER: 20905614 BUSINESS ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W CITY: KENNESAW STATE: GA ZIP: 30144 BUSINESS PHONE: 7704193355 MAIL ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W CITY: KENNESAW STATE: GA ZIP: 30144 8-K 1 cry-20200520x8k.htm 8-K cry-20200520x8k
false000078419900007841992020-05-202020-05-20





UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________________

FORM 8-K

___________________________________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 20, 2020

___________________________________________

CRYOLIFE, INC.

(Exact name of registrant as specified in its charter)

___________________________________________



 

 

Florida

1-13165

59-2417093

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1655 Roberts Boulevard, N.W., Kennesaw, Georgia  30144

(Address of principal executive office) (zip code)

Registrant's telephone number, including area code: (770) 419-3355

_________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.01 par value

CRY

NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 




Section 5

Corporate Governance and Management

Item 5.07

Submission of Matters to a Vote of Security Holders

At CryoLife, Inc.’s (the “Company” or “CryoLife”) 2020 Annual Meeting of Stockholders held on May 20, 2020 (the “Annual Meeting”), CryoLife’s stockholders elected each individual that was nominated for election as director of the Company to serve until the next annual meeting or until their successors are elected and have been qualified. The stockholders also (i) approved, by non-binding vote, the compensation paid to CryoLife’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, (ii) approved the new CryoLife, Inc. Equity and Cash Incentive Plan with funding of 2,675,000 shares, and (iii) ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2020.

The final results of the voting on each matter of business at the 2020 Annual Meeting are as follows:

Election of Directors

Name

Votes For

Votes Withheld

Broker Non-Votes

Thomas F. Ackerman

27,818,416

388,438

3,198,869

Daniel J. Bevevino

27,700,716

506,138

3,198,869

Marna P. Borgstrom

28,117,808

89,046

3,198,869

James W. Bullock

27,695,918

510,936

3,198,869

Jeffrey H. Burbank

27,696,171

510,683

3,198,869

J. Patrick Mackin

27,587,727

619,127

3,198,869

Ronald D. McCall, Esq.

23,527,589

4,679,265

3,198,869

Harvey Morgan

27,862,655

344,199

3,198,869

Jon W. Salveson

23,815,777

4,391,077

3,198,869

Approval, by non-binding vote of the compensation paid to CryoLife’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion.

Votes For

Votes Against

Votes Abstain

Broker Non-Votes

27,529,863

476,504

200,487

3,198,869

Approval of the new CryoLife, Inc. Equity and Cash Incentive Plan, with funding of 2,675,000 shares.

Votes For

Votes Against

Votes Abstain

Broker Non-Votes

27,109,999

912,110

184,745

3,198,869

Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2020.

Votes For

Votes Against

Votes Abstain

31,345,874

43,818

16,031


-2-


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 22, 2020



 

 

CRYOLIFE, INC. 

By:

/s/ D. Ashley Lee

Name:

D. Ashley Lee

Title:

Executive Vice President, Chief

Operating Officer and Chief

Financial Officer

-3-

EX-101.SCH 2 cry-20200520.xsd EX-101.SCH 00090 - Document - Document And Entity Informationlink:presentationLinklink:calculationLinklink:definitionLink EX-101.LAB 3 cry-20200520_lab.xml EX-101.LAB EX-101.PRE 4 cry-20200520_pre.xml EX-101.PRE XML 5 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.cryolife.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports cry-20200520x8k.htm cry-20200520.xsd cry-20200520_lab.xml cry-20200520_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end JSON 7 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cry-20200520x8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "cry-20200520x8k.htm" ] }, "labelLink": { "local": [ "cry-20200520_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "cry-20200520_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "cry-20200520.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "cry", "nsuri": "http://www.cryolife.com/20200520", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "cry-20200520x8k.htm", "contextRef": "Duration_5_20_2020_To_5_20_2020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document And Entity Information", "role": "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "cry-20200520x8k.htm", "contextRef": "Duration_5_20_2020_To_5_20_2020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "cry_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Document and Entity Information", "label": "Document And Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.cryolife.com/20200520", "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.cryolife.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 8 cry-20200520x8k_htm.xml IDEA: XBRL DOCUMENT 0000784199 2020-05-20 2020-05-20 false 0000784199 8-K 2020-05-20 CRYOLIFE, INC. FL 1-13165 59-2417093 1655 Roberts Boulevard, N.W. Kennesaw GA 30144 770 419-3355 false false false false Common Stock, $0.01 par value CRY NYSE false XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 10 0000784199-20-000143-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000784199-20-000143-xbrl.zip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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document And Entity Information
May 20, 2020
Document And Entity Information [Abstract]  
Document Type 8-K
Document Period End Date May 20, 2020
Entity Registrant Name CRYOLIFE, INC.
Entity Incorporation, State or Country Code FL
Entity File Number 1-13165
Entity Tax Identification Number 59-2417093
Entity Address, Address Line One 1655 Roberts Boulevard, N.W.
Entity Address, City or Town Kennesaw
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30144
City Area Code 770
Local Phone Number 419-3355
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol CRY
Security Exchange Name NYSE
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000784199
Amendment Flag false